{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:55:01Z","timestamp":1771905301081,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115372"],"award-info":[{"award-number":["115372"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-019-0525-9","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T20:04:53Z","timestamp":1566504293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Use of mild cognitive impairment and prodromal AD\/MCI due to AD in clinical care: a European survey"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2271-762X","authenticated-orcid":false,"given":"Daniela","family":"Bertens","sequence":"first","affiliation":[]},{"given":"Stephanie","family":"Vos","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Kehoe","sequence":"additional","affiliation":[]},{"given":"Henrike","family":"Wolf","sequence":"additional","affiliation":[]},{"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"Ineke","family":"van Rossum","sequence":"additional","affiliation":[]},{"given":"Jacub","family":"Hort","sequence":"additional","affiliation":[]},{"given":"Jose Luis","family":"Molinuevo","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Heneka","sequence":"additional","affiliation":[]},{"given":"Ron","family":"Petersen","sequence":"additional","affiliation":[]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"9518","key":"525_CR1","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"S Gauthier","year":"2006","unstructured":"Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367(9518):1262\u201370.","journal-title":"Lancet."},{"issue":"1","key":"525_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1212\/01.WNL.0000132523.27540.81","volume":"63","author":"M Ganguli","year":"2004","unstructured":"Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology. 2004;63(1):115\u201321.","journal-title":"Neurology."},{"issue":"12","key":"525_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1532-5415.2006.00976.x","volume":"54","author":"PJ Visser","year":"2006","unstructured":"Visser PJ. Mild cognitive impairment subtypes and vascular dementia. J Am Geriatr Soc. 2006;54(12):1966\u20137 author reply 1967-1968.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"525_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275(3):214\u201328 [cited 2016]. Available from: \n                    http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3967548&tool=pmcentrez&rendertype=abstract\n                    \n                  .","journal-title":"J Intern Med"},{"issue":"5","key":"525_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.0b013e3181eb5872","volume":"75","author":"JS Roberts","year":"2010","unstructured":"Roberts JS, Karlawish JH, Uhlmann WR, Petersen RC, Green RC. Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurol Int. 2010;75(5):425\u201331 Available from: \n                    http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2918467&tool=pmcentrez&rendertype=abstract\n                    \n                  .","journal-title":"Neurol Int"},{"issue":"3","key":"525_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21514249\n                    \n                  .","journal-title":"Alzheimers Dement"},{"key":"525_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, et al. Position paper advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"issue":"11","key":"525_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9(11):1118\u201327 Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442210702234\n                    \n                  .","journal-title":"Lancet Neurol"},{"issue":"2","key":"525_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2014.06.006","volume":"11","author":"M Bocchetta","year":"2015","unstructured":"Bocchetta M, Galluzzi S, Kehoe PG, et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimers Dement. 2015;11(2):195\u2013206.e1 [cited 2015]. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25150733\n                    \n                  .","journal-title":"Alzheimers Dement"},{"issue":"10","key":"525_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","volume":"17","author":"J Hort","year":"2010","unstructured":"Hort J, O\u2019Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer\u2019s disease. Eur J Neurol. 2010;17(10):1236\u201348 [cited 2015]. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20831773\n                    \n                  .","journal-title":"Eur J Neurol"},{"issue":"2","key":"525_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-2011-111694","volume":"29","author":"IA Van Rossum","year":"2012","unstructured":"Van Rossum IA, Visser PJ, Knol DL, et al. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer\u2019s disease. J Alzheimers Dis. 2012;29(2):319\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"525_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-170502","volume":"60","author":"AM Miller","year":"2017","unstructured":"Miller AM, Balasa M, Blennow K, et al. Current approaches and clinician attitudes to the use of cerebrospinal fluid biomarkers in diagnostic evaluation of dementia in Europe. J Alzheimers Dis. 2017;60(1):201\u201310.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"525_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jalz.2014.05.1753","volume":"11","author":"FH Duits","year":"2015","unstructured":"Duits FH, Prins ND, Lemstra AW, et al. Diagnostic impact of CSF biomarkers for Alzheimer\u2019s disease in a tertiary memory clinic. Alzheimers Dement. 2015;11(5):523\u201332.","journal-title":"Alzheimers Dement"},{"issue":"13","key":"525_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"GD Rabinovici","year":"2019","unstructured":"Rabinovici GD, Gatsonis C, Apgar C, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286-94. \n                    https:\/\/doi.org\/10.1001\/jama.2019.2000\n                    \n                  .","journal-title":"JAMA"},{"key":"525_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement."},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/bmm.12.58","volume":"6","author":"PJ Visser","year":"2012","unstructured":"Visser PJ, Wolf H, Frisoni G, Gertz H-J. Disclosure of Alzheimer\u2019s disease biomarker status in subjects with mild cognitive impairment. Biomark Med. 2012;6:365\u20138.","journal-title":"Biomark Med"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0525-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0525-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0525-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:15:41Z","timestamp":1597965341000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0525-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0525-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}